Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 6,761 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CHANGE Study Clear all

Conditions: Lupus Erythematosus, Systemic
Interventions: Ala-Cpn10, Placebo; Biological · Drug
Lead sponsor: Invion, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 6
States / cities: Miami, Florida • Chicago, Illinois • Altoona, Pennsylvania + 3 more

Conditions: Diabetes Mellitus
Interventions: Continuous Glucose Monitoring; Device
Lead sponsor: DexCom, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 3
States / cities: Concord, California • Escondido, California • Walnut Creek, California

Conditions: Pemphigus Vulgaris
Interventions: Ofatumumab, Placebo; Biological
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 7
States / cities: Los Angeles, California • Atlanta, Georgia • Ann Arbor, Michigan + 4 more

Conditions: Weight Maintenance, Weight Loss, Stress, Psychological, Job Stress, Diabetes Prevention, Obesity, Cardiovascular Risk Factor, Cardiovascular Diseases
Interventions: Diabetes Prevention Program; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Overweight
Interventions: Placebo, Orlistat; Drug
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Hemophilia, Menstrual Flow Excessive
Interventions: Recombinant FVIII Fc fusion product Eloctate, Recombinant FIX Fc fusion product Alprolix, Patient-operated diagnostic device for anemia AnemoCheck.; Drug · Device
Lead sponsor: Emory University; Other
Eligibility: 14 Years to 55 Years · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Minimal Residual Disease, KRAS G12D, KRAS G12R, NRAS G12D, NRAS G12R, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Cholangiocarcinoma, Bile Duct Cancer, Gallbladder Carcinoma
Interventions: ELI-002 2P; Drug
Lead sponsor: Elicio Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 10
States / cities: Duarte, California • Los Angeles, California • Aurora, Colorado + 7 more

Conditions: Implementation, Behavioral Symptoms
Interventions: Leadership for Organization Change and Implementation (LOCI), Training and Technical Assistance Only; Behavioral
Lead sponsor: Boise State University; Other
Eligibility: 4 Years and older
Enrollment: 686 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 4
States / cities: San Diego, California • Orlando, Florida • Boise, Idaho + 1 more

Conditions: Tics, Tourette Disorder, Tourette Syndrome in Children, Tourette Syndrome in Adolescence
Interventions: Habit Reversal Training; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 8 Years to 17 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Vaccine Reaction
Interventions: Not listed
Lead sponsor: physIQ, Inc.; Industry
Eligibility: Not listed
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes Mellitus, Type 1, Diabetes, Diabetes Complications
Interventions: Insulin Deprivation in Type 1 Diabetic Patients; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 14 Years to 45 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Pararenal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm
Interventions: PMEG; Device
Lead sponsor: Konstantinos Arnaoutakis, MD; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Wesley Chapel, Florida

Conditions: Breast Cancer
Interventions: Pembrolizumab, Nab-Paclitaxel, Biopsy; Drug · Procedure
Lead sponsor: Adrienne G. Waks; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism Spectrum Disorder (ASD), Developmental Disability
Interventions: Diné Parents Taking Action Program; Behavioral
Lead sponsor: Northern Arizona University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Flagstaff, Arizona

Conditions: Behavior Problems, Parent-Child Relations
Interventions: Motivational Interviewing, Anticipatory Guidance on Child Development; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 2 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer, PR-Positive Breast Cancer
Interventions: Infigratinib, Tamoxifen, Omnipaque 350, Iopamidol, Computed tomography (CT); Drug · Diagnostic Test
Lead sponsor: Jennifer Lee Caswell-Jin; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Epilepsy, Cerebral Palsy, Developmental Delay
Interventions: Dexmedetomidine bolus and high infusion-Propofol, Dexmedetomidine bolus and low infusion-Propofol, Dexmedetomidine bolus only - Propofol; Drug
Lead sponsor: Joseph Cravero; Other
Eligibility: 1 Year to 12 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Asthma in Children
Interventions: Standard of Care Education, Interactive Video (IAV) Telemedicine; Behavioral · Other
Lead sponsor: University of Arkansas; Other
Eligibility: 5 Years to 18 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Brain Metastases, Brain Metastases, Adult, Metastatic Brain Tumor, Metastatic Brain Cancer
Interventions: CEST-MRF; Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Hyperparathyroidism, Primary
Interventions: 18F-Fluorocholine, Positron emission tomography (PET); Drug · Procedure
Lead sponsor: Thomas Hope; Other
Eligibility: 13 Years and older
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension, Stress, Cardiovascular Diseases
Interventions: MBCT-T, Usual Care; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity & Overweight
Interventions: Standard Medical Care with an Obesity Management Medication, Cardiovascular Exercise Training, Resistance Exercise Training, Nutrition Counseling; Other · Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Glioma, Glioma (Any Grade) in the Brain, Glioblastom WHO Grade 4, Glioblastoma, Glioblastoma (GBM), Grade III Astrocytoma, Grade II Glioma, Grade IV Astrocytoma, Grade IV Glioma, Grade III Glioma
Interventions: Connectome MRI, Neuropsychological testing; Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 1
States / cities: New York, New York

Conditions: Pregnancy Related
Interventions: Exercise in Pregnancy; Behavioral
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Little Rock, Arkansas

Search by objective public record fields.

Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.

Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified Algorithm

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

The SCULPT-Job Cohort Study

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Working to Implement and Sustain Digital Outcome Measures

Investigating Changes in Premonitory Urges During Habit Reversal Training for Tics

(VIII): The Eight Study and Immunologic Response Sub-study

Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes

PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm

A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer

Diné Parents Taking Action Trial

Motivational Interviewing to Increase Parent Engagement in Preventive Parenting Programming

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers

Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Stress Management to Support Women's Health

Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise

Observational Connectomics in Adults Undergoing Resection of WHO II-IV Glioma

Community Translation of the Expecting Study